Allied Market Research
Loading...
0
New
New
2021
Urinary Incontinence Market

Urinary Incontinence Market by Product (Devices and Disposables), Incontinence Type (Stress Urinary Incontinence, Urge Urinary Incontinence, Overflow Urinary Incontinence, and Functional Urinary Incontinence), and End User (Hospitals and Clinics, Home Care, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

A14142
Pages: 296
Oct 2021 | 200 Views
   
Author(s) : Kishor Sherkar, Ajinkya Alhat , Onkar Sumant
Tables: 155
Charts: 64
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Urinary Incontinence Market

Request Now !

Urinary Incontinence Market Overview:

The global urinary incontinence market size was valued at $10,124.33 million in 2020, and is projected to reach $19,341.15 million by 2030, registering a CAGR of 6.8% from 2021 to 2030. Any involuntary urine leakage is referred to as incontinence. A broken sphincter or a malfunctioning bladder are the most common causes of male urinary incontinence. The sphincter is a circular muscle in the bladder that regulates urine flow. When this muscle is injured, it loses its ability to squeeze and seal the urethra, the tube that transports urine from the bladder to the outside of the body. Urinary incontinence devices assist in the collection and retention of urine and aid in the effective management of urinary incontinence. Urinary incontinence causes uncontrollable urine leakage

The COVID-19 pandemic is an unprecedented global public health challenge and is anticipated to have a negative impact on the urinary incontinence market. Outpatient clinics for female urinary incontinence, benign prostatic hyperplasia, infertility, and sexual medicine, benign scrotal conditions, renal stone, and bladder stone were mostly affected. Moreover, during the COVID-19 pandemic in 2020, there was a significant reduction in several types of outpatient tests and treatments, with surgical treatments for female urinary incontinence, infertility, kidney stones, and bladder stones having the greatest rates of cut-down services.

Increase in prevalence of urological disorders and development of advanced urinary incontinence device boost the growth of urinary incontinence market. In addition, rise in demand for minimally invasive operations, as well as an aging population that is more prone to urological problems drive the growth of the urinary incontinence device market. Furthermore, the number of urinary incontinent patients switching from traditional methods is expected to rise in the near future. The expansion of the market is aided by the increase in risk of associative urological disorders among people. However, the growth of the urinary incontinence market is hampered by a lack of awareness about new improvements in urinary incontinence devices and post-operative difficulties linked with the devices. Furthermore, rise in healthcare spending in developing nations is expected to open up new growth opportunities.

urinary-incontinence-market-2021-2030

Get more information on this report : Request Sample Pages

The outbreak of COVID-19 has disrupted workflows in the health care sector across the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. The overall impact of the COVID-19 pandemic remained negative for key players in the urinary incontinence industry. Outpatient clinics for female urinary incontinence, benign prostatic hyperplasia, infertility, and sexual medicine, benign scrotal conditions, renal stone, and bladder stone were most affected, according to a 2020 research study by Jeremy Yuen-Chun Teoh et al. titled 'A Global Survey on the Impact of COVID-19 on Urological Services. Moreover, during the COVID-19 pandemic 2020, there was a significant reduction in many types of outpatient tests and treatments, with surgical treatments for female urinary incontinence, infertility, kidney stones, and bladder stones having the greatest rates of cut-down services. Furthermore, due to COVID, several market players experienced a revenue drop in the urology platform. For instance, in the fiscal year 2019-20, Coloplast Corp.'s interventional urology segment experienced negative organic growth of -7 percent. The drop in sales of Altis single-incision slings and other goods was mostly due to the cancellation of elective operations and treatments in the United States as a result of the COVID-19 outbreak. Moreover, the elective procedures outside the U.S. were also postponed in several countries, due to the COVID-19 outbreak. 

Urinary Incontinence Market Segmentation

The urinary incontinence market is segmented on the basis of product, incontinence type, end user, and region. By product, the market is divided into devices and disposables. The devices segment is further bifurcated into urinary catheters, vaginal slings, Electrical stimulation devices, artificial urinary sphincters, other devices and category. Urinary catheters are sub segmented into Foley catheters and other urinary catheters. Vaginal slings segment is sub segmented into conventional vaginal slings and advanced vaginal slings. On the basis of category, it is classified into external urinary incontinence devices and internal urinary incontinence devices. The disposables segment is further divided into disposable underwear, disposable shields, disposable diapers, disposable underpads, and others. By incontinence type, the market is categorized into stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and functional urinary incontinence. Further, by end user, it is classified into hospitals and clinics, homecare, and others. By region, the urinary incontinence market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment review 

By product, the disposables segment currently dominates the global urinary incontinence market and is expected to continue during the forecast period owing to the repetitive use or consumption along with repetitive purchase of urinary incontinence disposables.

Urinary Incontinence Market
By Product

Your browser does not support the canvas element.

Disposables Segment dominated the market in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

By incontinence type, the stress urinary incontinence (SUI) segment dominated the global urinary incontinence market in 2020. This is attributed to high incidence of stress urinary incontinence witnessed among women globally. The epidemiological studies on the stress urinary incontinence in women have concluded that approximately 50% of women with urinary incontinence report symptoms of stress incontinence. 

By end user, the hospital and clinics segment dominated the global urinary incontinence market in 2020 and is anticipated to continue this trend during the forecast period owing to urinary incontinence most commonly affects women and the prevalence is high among hospitalized older adults. Thus, the hospital segment has displayed maximum adoption of the urinary incontinence devices as large patient pool suffering from chronic conditions or pregnancy are associated with urinary incontinence. 

Urinary Incontinence Market
By Incontinence type

Your browser does not support the canvas element.

Stress Urinary Incontinence segment held a dominant position in 2020.

Get more information on this report : Request Sample Pages

Region segment review

Region wise, North America dominated the market in 2020, owing to increase in prevalence of urinary incontinence in North America along with early adoption of novel urinary incontinence devices along with increase in prevalence of stress urinary incontinence among women in this region. However, Asia-Pacific is expected to register the highest CAGR in terms of revenue during the forecast period, owing to growth in healthcare expenditures in the developing economies of this region.

The key players in this market have adopted product launch as one of their key developmental strategies such as acquisitions and product launches. The major companies profiled in this report include Becton, Dickinson and Company (C.R. Bard Inc.), Boston Scientific Corporation, Caldera Medical, Coloplast A/S, ConvaTec Group plc, Cook Group Inc., Johnson and Johnson, Laborie Medical, Medtronic plc, Teleflex Incorporated, Ahlstrom-Munksjo, Asahi Kasei Corporation, Berry Global Inc., Cardinal Health, Inc., Domtar Corporation, First Quality Enterprises, Inc., Freudenberg & Co. KG, Georgia-Pacific LLC, Kimberly-Clark Corporation, and Unicharm Corporation.

Urinary Incontinence Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

Asia- Pacific region would exhibit the fastest CAGR of 8.2% during the forecast period.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global urinary incontinence market along with the current trends and future estimations to explain the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the urinary incontinence market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing urinary incontinence market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of urinary incontinence device used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the urinary incontinence market.

Key Market Segments

By Product

  • Devices
    • Urinary Catheters
      • Foley Catheters
      • Other Urinary Catheters
    • Vaginal Slings
      • Conventional Vaginal Slings
      • Advanced Vaginal Slings
    • Electrical Stimulation Devices
    • Artificial Urinary Sphincters
    • Other Devices
    • Category
      • External Urinary Incontinence Devices
      • Internal Urinary Incontinence Devices
  • Disposables
    • Disposable Underwear
    • Disposable Shields
    • Disposable Diapers
    • Disposable Underpads
    • Others

By Incontinence Type

  • Stress Urinary Incontinence
  • Urge Urinary Incontinence
  • Overflow Urinary Incontinence
  • Functional Urinary Incontinence

By End User

  • Hospitals and Clinics
  • Home Care
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

List of key players profiled in the report:

  • Becton, Dickinson and Company (C.R. Bard Inc.)
  • Boston Scientific Corporation
  • Caldera Medical
  • Coloplast A/S
  • ConvaTec Group PLC
  • Cook Group Inc.
  • Johnson and Johnson
  • Laborie Medical
  • Medtronic plc
  • Teleflex Incorporated
  • Ahlstrom-Munksjo
  • Asahi Kasei Corporation
  • Berry Global Inc.
  • Cardinal Health, Inc.
  • Domtar Corporation
  • First Quality Enterprises, Inc.
  • Freudenberg & Co. KG
  • Georgia-Pacific LLC
  • Kimberly-Clark Corporation
  • Unicharm Corporation
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s Five Forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Development of innovative urinary incontinence devices & rising 
demand for minimally invasive procedures
3.5.1.2.Increase in aging population coupled with high risk of urological 
disorders
3.5.1.3.Rise in shift from conventional solutions to novel urinary incontinent products
3.5.1.4.Growth in elderly population
3.5.1.5.Efficiency in the prevention of hospital-acquired infections (HAIs)

3.5.2.Restraints

3.5.2.1.Lack of awareness regarding novel developments in the urinary incontinence devices coupled with underreported cases of urinary incontinence
3.5.2.2.Post-operative complications associated with the devices
3.5.2.3.Rise in concerns toward disposal products

3.5.3.Opportunities

3.5.3.1.Growth in healthcare expenditures in the developing economies
3.5.3.2.Rise in technology integration

3.5.4.Impact analysis

3.6.COVID-19 Impact analysis on urinary incontinence market

CHAPTER 4:URINARY INCONTINENCE MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Devices

4.2.1.Key market trends, growth factors and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market size and forecast, by devices
4.2.4.Market share analysis, by country
4.2.5.Urinary catheters

4.2.5.1.Key trends and opportunities
4.2.5.2.Market size and forecast
4.2.5.3.Foley catheters
4.2.5.4.Other urinary catheters

4.2.6.Vaginal slings

4.2.6.1.Key trends and opportunities
4.2.6.2.Market size and forecast
4.2.6.3.Conventional vaginal slings
4.2.6.4.Advanced vaginal slings

4.2.7.Electrical stimulation devices

4.2.7.1.Key trends and opportunities

4.2.8.Artificial urinary sphincters

4.2.8.1.Key trends and opportunities

4.2.9.Other devices

4.2.9.1.Key trends and opportunities

4.2.10.Urinary incontinence devices market size and forecast, by category

4.2.10.1.Market size and forecast
4.2.10.2.External urinary incontinence devices
4.2.10.3.Internal urinary incontinence devices

4.3.Disposables

4.3.1.Market size and forecast
4.3.2.Market size and forecast, by region
4.3.3.Market share analysis, by country
4.3.4.Disposable underwear

4.3.4.1.Key market trends and opportunities

4.3.5.Disposable shields

4.3.5.1.Key market trends and growth opportunities

4.3.6.Disposable diapers

4.3.6.1.Key market trends and opportunities

4.3.7.Disposable underpads

4.3.7.1.Key market trends and opportunities

4.3.8.Others

4.3.8.1.Key market trends and opportunities

CHAPTER 5:URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Stress urinary incontinence

5.2.1.Market size and forecast by region.
5.2.2.Market analysis, by country

5.3.Urge urinary incontinence

5.3.1.Market size and forecast by region.
5.3.2.Market analysis, by country

5.4.Overflow urinary incontinence

5.4.1.Market size and forecast by region
5.4.2.Market analysis, by country

5.5.Functional urinary incontinence

5.5.1.Market size and forecast by region
5.5.2.Market analysis, by country

CHAPTER 6:URINARY INCONTINENCE MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals and Clinics

6.2.1.Market size and forecast by region.
6.2.2.Market analysis, by country

6.3.Home Care

6.3.1.Market size and forecast by region
6.3.2.Market share analysis, by country

6.4.Others

6.4.1.Market size and forecast by region.
6.4.2.Market share analysis, by country

CHAPTER 7:URINARY INCONTINENCE MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by product
7.2.3.Market size and forecast, by incontinence type
7.2.4.Market size and forecast, by end user
7.2.5.Market size & forecast, by country

7.2.5.1.U.S.

7.2.5.1.1.Market size and forecast, by product
7.2.5.1.2.Market size and forecast, by incontinence type
7.2.5.1.3.Market size and forecast by end user

7.2.5.2.Canada

7.2.5.2.1.Market size and forecast, by product
7.2.5.2.2.Market size and forecast by incontinence type
7.2.5.2.3.Market size and forecast, by end user

7.2.5.3.Mexico

7.2.5.3.1.Market size and forecast by product
7.2.5.3.2.Market size and forecast, by incontinence type
7.2.5.3.3.Market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors and opportunities
7.3.2.Market size and forecast, by product
7.3.3.Market size and forecast, by incontinence type
7.3.4.Market size and forecast, by end user
7.3.5.Europe market size & forecast, by country

7.3.5.1.Germany

7.3.5.1.1.Market size and forecast, by product
7.3.5.1.2.Market size and forecast, by incontinence type
7.3.5.1.3.Market size and forecast by end user

7.3.5.2.France

7.3.5.2.1.Market size and forecast by product
7.3.5.2.2.Market size and forecast by incontinence type
7.3.5.2.3.Market size and forecast by end user

7.3.5.3.UK

7.3.5.3.1.Market size and forecast by product
7.3.5.3.2.Market size and forecast by incontinence type
7.3.5.3.3.Market size and forecast by end user

7.3.5.4.Italy

7.3.5.4.1.Market size and forecast by product
7.3.5.4.2.Market size and forecast by incontinence type
7.3.5.4.3.Market size and forecast by end user

7.3.5.5.Spain

7.3.5.5.1.Market size and forecast by product
7.3.5.5.2.Market size and forecast by incontinence type
7.3.5.5.3.Market size and forecast by end user

7.3.5.6.Rest of Europe

7.3.5.6.1.Market size and forecast by product
7.3.5.6.2.Market size and forecast by incontinence type
7.3.5.6.3.Market size and forecast by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors and opportunities
7.4.2.Market size and forecast, by product
7.4.3.Market size and forecast, by incontinence type
7.4.4.Market size and forecast, by end user
7.4.5.Asia-Pacific market size & forecast, by country

7.4.5.1.Japan

7.4.5.1.1.Market size and forecast, by product
7.4.5.1.2.Market size and forecast, by incontinence type
7.4.5.1.3.Market size and forecast by end user

7.4.5.2.China

7.4.5.2.1.Market size and forecast, by product
7.4.5.2.2.Market size and forecast, by incontinence type
7.4.5.2.3.Market size and forecast by end user

7.4.5.3.Australia

7.4.5.3.1.Market size and forecast, by product
7.4.5.3.2.Market size and forecast, by incontinence type
7.4.5.3.3.Market size and forecast by end user

7.4.5.4.India

7.4.5.4.1.Market size and forecast, by product
7.4.5.4.2.Market size and forecast, by incontinence type
7.4.5.4.3.Market size and forecast by end user

7.4.5.5.South Korea

7.4.5.5.1.Market size and forecast, by product
7.4.5.5.2.Market size and forecast, by incontinence type
7.4.5.5.3.Market size and forecast by end user

7.4.5.6.Rest of Asia-Pacific

7.4.5.6.1.Market size and forecast, by product
7.4.5.6.2.Market size and forecast, by incontinence type
7.4.5.6.3.Market size and forecast by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors and opportunities
7.5.2.Market size and forecast, by product
7.5.3.Market size and forecast, by incontinence type
7.5.4.Market size and forecast, by end user
7.5.5.LAMEA market size & forecast, by country

7.5.5.1.Brazil

7.5.5.1.1.Market size and forecast, by product
7.5.5.1.2.Market size and forecast, by incontinence type
7.5.5.1.3.Market size and forecast by end user

7.5.5.2.Saudi Arabia

7.5.5.2.1.Market size and forecast, by product
7.5.5.2.2.Market size and forecast, by incontinence type
7.5.5.2.3.Market size and forecast by end user

7.5.5.3.South Africa

7.5.5.3.1.Market size and forecast, by product
7.5.5.3.2.Market size and forecast, by incontinence type
7.5.5.3.3.Market size and forecast by end user

7.5.5.4.Rest of LAMEA

7.5.5.4.1.Market size and forecast, by product
7.5.5.4.2.Market size and forecast, by incontinence type
7.5.5.4.3.Market size and forecast by end user

CHAPTER 8:COMPANY PROFILES

8.1.BECTON, DICKINSON AND COMPANY (C.R. BARD INC.)

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance

8.2.BOSTON SCIENTIFIC CORPORATION

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments

8.3.CALDERA MEDICAL

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio

8.4.COLOPLAST A/S

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments

8.5.CONVATEC GROUP PLC

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance

8.6.COOK GROUP INC. (COOK MEDICAL INC.)

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio

8.7.JOHNSON & JOHNSON (ETHICON INC.)

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance

8.8.LABORIE MEDICAL (COGENTIX MEDICAL INC.)

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio

8.9.MEDTRONIC PLC

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance

8.10.TELEFLEX INCORPORATED

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance

8.11.AHLSTROM-MUNKSJO

8.11.1.Company overview
8.11.2.Company snapshot
8.11.3.Operating business segments
8.11.4.Product portfolio
8.11.5.Business performance
8.11.6.Key strategic moves and developments

8.12.ASAHI KASEI CORPORATION

8.12.1.Company overview
8.12.2.Company snapshot
8.12.3.Operating business segments
8.12.4.Product portfolio
8.12.5.Business performance
8.12.6.Key strategic moves and developments

8.13.BERRY GLOBAL INC.

8.13.1.Company overview
8.13.2.Company snapshot
8.13.3.Operating business segments
8.13.4.Product portfolio
8.13.5.Business performance

8.14.CARDINAL HEALTH, INC.

8.14.1.Company overview
8.14.2.Company snapshot
8.14.3.Operating business segments
8.14.4.Product portfolio
8.14.5.Business performance

8.15.DOMTAR CORPORATION

8.15.1.Company overview
8.15.2.Operating business segments
8.15.3.Product portfolio
8.15.4.Business performance
8.15.5.Key strategic moves and developments

8.16.FIRST QUALITY ENTERPRISES, INC.

8.16.1.Company overview
8.16.2.Company snapshot
8.16.3.Operating business segments
8.16.4.Product portfolio
8.16.5.Key strategic moves and developments

8.17.FREUDENBERG & CO. KG

8.17.1.Company overview
8.17.2.Company snapshot
8.17.3.Operating business segments
8.17.4.Product portfolio

8.18.GEORGIA-PACIFIC LLC

8.18.1.Company overview
8.18.2.Company snapshot
8.18.3.Operating business segments
8.18.4.Product portfolio

8.19.KIMBERLY-CLARK CORPORATION

8.19.1.Company overview
8.19.2.Company snapshot
8.19.3.Operating business segment
8.19.4.Product portfolio
8.19.5.Business performance

8.20.UNICHARM CORPORATION

8.20.1.Company Overview
8.20.2.Company snapshot
8.20.3.Operating business segments
8.20.4.Product portfolio
8.20.5.Business performance

LIST OF TABLES

TABLE 01.URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 02.URINARY INCONTINENCE MARKET FOR DEVICES, BY REGION, 2020-2030, ($MILLION)
TABLE 03.GLOBAL URINARY INCONTINENCE MARKET FOR DEVICES, 2020-2030, ($MILLION)
TABLE 04.GLOBAL URINARY INCONTINENCE MARKET FOR URINARY CATHETERS, 2020-2030 ($MILLION)
TABLE 05.EXAMPLE OF ANTI-MICROBIAL FOLEY CATHETER URINARY INCONTINENCE
TABLE 06.GLOBAL URINARY INCONTINENCE MARKET FOR VAGINAL SLINGS, 2020–2030, ($MILLION)
TABLE 07.GLOBAL URINARY INCONTINENCE MARKET, BY CATEGORY, 2020–2030, ($MILLION)
TABLE 08.URINARY INCONTINENCE MARKET FOR DISPOSABLE PRODUCTS, 2020-2030 ($MILLION)
TABLE 09.URINARY INCONTINENCE MARKET FOR DISPOSABLE PRODUCTS, BY REGION, 2020-2030, ($MILLION)
TABLE 10.GLOBAL URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 11.DEVICES USED IN THE TREATMENT OF STRESS URINARY INCONTINENCE
TABLE 12.STRESS URINARY INCONTINENCE MARKET, BY REGION, 2020-2030 ($ MILLION)
TABLE 13.EXAMPLE OF ELECTROSTIMULATION DEVICE USED IN THE TREATMENT OF URGE URINARY 
INCONTINENCE107
TABLE 14.URGE URINARY INCONTINENCE MARKET, BY REGION, 2020-2030 ($ MILLION)
TABLE 15.DEVICES USED IN THE TREATMENT OF OVERFLOW URINARY INCONTINENCE
TABLE 16.OVERFLOW URINARY INCONTINENCE MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 17.FUNCTIONAL URINARY INCONTINENCE MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 18.GLOBAL URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($ MILLION)
TABLE 19.URINARY INCONTINENCE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2030 ($ MILLION)
TABLE 20.URINARY INCONTINENCE MARKET FOR HOME CARE, BY REGION, 2020-2030 ($ MILLION)
TABLE 21.URINARY INCONTINENCE MARKET FOR OTHERS, BY REGION, 2020-2030 ($ MILLION)
TABLE 22.GLOBAL URINARY INCONTINENCE MARKET, BY REGION, 2020-2030($MILLION)
TABLE 23.NORTH AMERICA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 24.NORTH AMERICA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 25.NORTH AMERICA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 26.NORTH AMERICA URINARY INCONTINENCE MARKET BY COUNTRY, 2020-2030($MILLION)
TABLE 27.U.S. URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 28.U.S. URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 29.U.S. URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 30.CANADA URINARY INCONTINENCE MARKET, BY PRODUCT, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 31.CANADA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 32.CANADA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 33.MEXICO URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 34.MEXICO URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 35.MEXICO URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 36.EUROPE URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 37.EUROPE URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 38.EUROPE URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 39.EUROPE URINARY INCONTINENCE MARKET BY COUNTRY, 2020-2030 ($MILLION)
TABLE 40.GERMANY URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 41.GERMANY URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 42.GERMANY URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 43.FRANCE URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 44.FRANCE URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 45.FRANCE URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 46.UK URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 47.UK URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 48.UK URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 49.ITALY URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 50.ITALY URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 51.ITALY URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 52.SPAIN URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 53.SPAIN URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 54.SPAIN URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 55.REST OF EUROPE URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 56.REST OF EUROPE URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 57.REST OF EUROPE URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 58.ASIA-PACIFIC URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 59.ASIA-PACIFIC URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 60.ASIA-PACIFIC URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 61.ASIA PACIFIC URINARY INCONTINENCE MARKET BY COUNTRY, 2020-2030($MILLION)
TABLE 62.JAPAN URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 63.JAPAN URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 64.JAPAN URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 65.CHINA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 66.CHINA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 67.CHINA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 68.AUSTRALIA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 69.AUSTRALIA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 70.AUSTRALIA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 71.INDIA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 72.INDIA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 73.INDIA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 74.SOUTH KOREA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 75.SOUTH KOREA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 76.SOUTH KOREA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 77.REST OF ASIA-PACIFIC URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 78.REST OF ASIA-PACIFIC URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 
2020-2030 ($MILLION)
TABLE 79.REST OF ASIA-PACIFIC URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 80.LAMEA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 81.LAMEA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 82.LAMEA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 83.LAMEA URINARY INCONTINENCE MARKET BY COUNTRY, 2020-2030($MILLION)
TABLE 84.BRAZIL URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 85.BRAZIL URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 86.BRAZIL URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 87.SAUDI ARABIA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 88.SAUDI ARABIA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 89.SAUDI ARABIA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 90.SOUTH AFRICA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 91.SOUTH AFRICA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030($MILLION)
TABLE 92.SOUTH AFRICA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 93.REST OF LAMEA URINARY INCONTINENCE MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 94.REST OF LAMEA URINARY INCONTINENCE MARKET, BY INCONTINENCE TYPE, 2020-2030 ($MILLION)
TABLE 95.REST OF LAMEA URINARY INCONTINENCE MARKET, BY END USER, 2020-2030($MILLION)
TABLE 96.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 97.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 98.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 99.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 100.BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 101.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 102.CALDERA: COMPANY SNAPSHOT
TABLE 103.CALDERA: OPERATING SEGMENTS
TABLE 104.CALDERA: PRODUCT PORTFOLIO
TABLE 105.COLOPLAST: COMPANY SNAPSHOT
TABLE 106.COLOPLAST: OPERATING SEGMENTS
TABLE 107.COLOPLAST: PRODUCT PORTFOLIO
TABLE 108.CONVATEC: COMPANY SNAPSHOT
TABLE 109.CONVATEC: OPERATING SEGMENTS
TABLE 110.CONVATEC: PRODUCT PORTFOLIO
TABLE 111.COOK GROUP: COMPANY SNAPSHOT
TABLE 112.COOK GROUP: OPERATING SEGMENTS
TABLE 113.COOK GROUP: PRODUCT PORTFOLIO
TABLE 114.JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 115.JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 116.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 117.LABORIE MEDICAL: COMPANY SNAPSHOT
TABLE 118.LABORIE: OPERATING SEGMENTS
TABLE 119.LABORIE: PRODUCT PORTFOLIO
TABLE 120.MEDTRONIC: COMPANY SNAPSHOT
TABLE 121.MEDTRONIC: OPERATING SEGMENTS
TABLE 122.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 123.TELEFLEX: COMPANY SNAPSHOT
TABLE 124.TELEFLEX: OERATING SEGMENT
TABLE 125.TELEFLEX: PRODUCT PORTFOLIO
TABLE 126.AHLSTROM: COMPANY SNAPSHOT
TABLE 127.AHLSTROM: OPERATING BUSINESS SEGMENTS
TABLE 128.AHLSTROM: PRODUCT PORTFOLIO
TABLE 129.ASAHI KASEI: COMPANY SNAPSHOT
TABLE 130.ASAHI KASEI: PRODUCT BUSINESS SEGMENT
TABLE 131.ASAHI KASEI: PRODUCT PORTFOLIO
TABLE 132.BERRY: COMPANY SNAPSHOT
TABLE 133.BERRY: OPERATING BUSINESS SEGMENTS
TABLE 134.BERRY: PRODUCT PORTFOLIO
TABLE 135.CARDINAL: COMPANY SNAPSHOT
TABLE 136.CARDINAL: OPERATING SEGMENTS
TABLE 137.CARDINAL: PRODUCT PORTFOLIO
TABLE 138.DOMTAR.: COMPANY SNAPSHOT
TABLE 139.DOMTAR.: OPERATING BUSINESS SEGMENTS
TABLE 140.DOMTAR.: PRODUCT PORTFOLIO
TABLE 141.FIRST QUALITY: COMPANY SNAPSHOT
TABLE 142.FIRST QUALITY: OPERATING BUSINESS SEGMENTS
TABLE 143.FIRST QUALITY: PRODUCT PORTFOLIO
TABLE 144.FREUDENBERG: COMPANY SNAPSHOT
TABLE 145.FREUDENBERG NONWOVENS: OPERATING SEGMENT
TABLE 146.FREUDENBERG: PRODUCT PORTFOLIO
TABLE 147.GEORGIA: COMPANY SNAPSHOT
TABLE 148.GEORGIA: OPERATING SEGMENTS
TABLE 149.GEORGIA: PRODUCT PORTFOLIO
TABLE 150.KIMBERLY: COMPANY SNAPSHOT
TABLE 151.KIMBERLY: OPERATING SEGMENT
TABLE 152.KIMBERLY: PRODUCT PORTFOLIO
TABLE 153.UNICHARM: COMPANY SNAPSHOT
TABLE 154.UNICHARM: OPERATING SEGMENTS
TABLE 155.UNICHARM: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.SEGMENTATION OF URINARY INCONTINENCE MARKET
FIGURE 02.TOP INVESTMENT POCKETS IN URINARY INCONTINENCE MARKET, 2020
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019-2021*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTION
FIGURE 09.MODERATE THREAT OF NEW ENTRANT
FIGURE 10.MODERATE COMPETITIVE RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, URINARY INCONTINENCE DEVICES MARKET, 2020
FIGURE 12.TOP PLAYER POSITIONING, DISPOSABLE INCONTINENCE PRODUCTS MARKET, 2020
FIGURE 13.IMPACT ANALYSIS
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF URINARY INCONTINENCE MARKET FOR DEVICES,  
BY COUNTRY, 2020 & 2030 (%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF URINARY INCONTINENCE MARKET FOR DISPOSABLE PRODUCTS, 
BY COUNTRY, 2020 & 2030 (%)
FIGURE 16.MARKET SIZE AND FORECAST OF STRESS URINARY INCONTINENCE MARKET, BY COUNTRY, 
BY COUNTRY, 2020 & 2030 (%)
FIGURE 17.MARKET SIZE AND FORECAST OF URGE URINARY INCONTINENCE MARKET, BY COUNTRY, 
2020 & 2030 (%)
FIGURE 18.MARKET SIZE AND FORECAST OF OVERFLOW URINARY INCONTINENCE MARKET,  BY COUNTRY, 
2020 & 2030(%)
FIGURE 19.MARKET SIZE AND FORECAST OF FUNCTIONAL URINARY INCONTINENCE MARKET,  BY COUNTRY, 
2020 & 2030(%)
FIGURE 20.MARKET SIZE AND FORECAST OF URINARY INCONTINENCE FOR HOSPITALS & CLINICS, 
BY COUNTRY, 2020 & 2030(%)
FIGURE 21.MARKET SIZE AND FORECAST OF URINARY INCONTINENCE MARKET FOR HOME CARE,  
BY COUNTRY, 2020 & 2030(%)
FIGURE 22.MARKET SIZE AND FORECAST OF URINARY INCONTINENCE MARKET FOR OTHERS, BY COUNTRY, 
2020 & 2030(%)
FIGURE 23.BECTON, DICKINSON AND COMPANY: NET SALES, 2018–2020 ($MILLION)
FIGURE 24.BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 25.BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 26.BOSTON SCIENTIFIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 27.BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 28.BOSTON SCIENTIFIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 29.COLOPLAST: NET SALES, 2018–2020 ($MILLION)
FIGURE 30.COLOPLAST: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31.COLOPLAST: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 32.CONVATEC: NET SALES, 2018–2020 ($MILLION)
FIGURE 33.CONVATEC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34.CONVATEC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 35.JOHNSON & JOHNSON: NET SALES, 2018–2020 ($MILLION)
FIGURE 36.JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37.JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 39.MEDTRONIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40.MEDTRONIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 41.TELEFLEX: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.TELEFLEX: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 43.TELEFLEX: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 44.AHLSTROM: NET SALES, 2018–2020 ($MILLION)
FIGURE 45.AHLSTROM: REVENUE SHARE BY SEGMENT, 2020(%)
FIGURE 46.AHLSTROM: REVENUE SHARE BY REGION, 2020(%)
FIGURE 47.ASAHI KASEI: NET SALES, 2018–2020 ($MILLION)
FIGURE 48.ASAHI KASEI: REVENUE SHARE BY SEGMENT, 2020(%)
FIGURE 49.BERRY: NET SALES, 2018–2020 ($MILLION)
FIGURE 50.BERRY: REVENUE SHARE BY REGION SEGMENT, 2020(%)
FIGURE 51.BERRY: REVENUE SHARE BY REGION, 2020(%)
FIGURE 52.CARDINAL: NET SALES, 2018–2020 ($MILLION)
FIGURE 53.CARDINAL: REVENUE SHARE BY SEGMENT, 2020(%)
FIGURE 54.CARDINAL: REVENUE SHARE BY REGION, 2020(%)
FIGURE 55.DOMTAR: NET SALES, 2018–2020 ($MILLION)
FIGURE 56.DOMTAR: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 57.FREUDENBERG: NET SALES, 2018–2020 ($MILLION)
FIGURE 58.FREUDENBERG: REVENUE BY SEGMENT, 2020 (%)
FIGURE 59.FREUDENBERG: REVENUE BY REGION, 2018(%)
FIGURE 60.KIMBERLY: NET SALES, 2018–2020 ($MILLION)
FIGURE 61.KIMBERLY: REVENUE BY SEGMENT, 2020 (%)
FIGURE 62.KIMBERLY: REVENUE BY REGION, 2020 (%)
FIGURE 63.UNICHARM: NET SALES, 2018–2020 ($MILLION)
FIGURE 64.UNICHARM: REVENUE SHARE BY SEGMENT, 2020 (%)

 
 

This section provides various opinions of the top-level CXOs in urinary incontinence market. In accordance to several interviews conducted, the utilization of such devices is projected to witness a significant rise with growth in number of incontinent patients across the globe. The urinary incontinence market is largely fragmented, and bargaining power of suppliers clearly varies in patient centric medical app devices and patient centric medical app services market. Technological innovation is turning out to be a principal strategy to increase bargaining power of buyers.

The urinary incontinence market has gained the interest of healthcare professionals, patients, and surgeons owing to improved care of patients suffering from involuntary urine leakage. There have been remarkable technological advancements in the development of novel urinary incontinence devices including mini-slings, single-incision slings, advanced catheters, and electrical stimulation devices. As the market is growing at a steady rate in the developed nations, Asia-Pacific and Europe are expected to offer high growth opportunities to the key players in this market.

In addition, patients suffering from chronic ailments such as multiple sclerosis, Parkinson's disease, a stroke, a brain tumor, and spinal injury are affected by associated urinary incontinence. This offers large patient pool suffering from incontinence demanding development of novel devices for the management of the same.

A rise in demand for surgical treatment of urinary incontinence targeted toward an early cure, increase in geriatric population with a high risk of urinary incontinence, rise in the novel urinary incontinent products, and improvement in the prevention of hospital-acquired infections are the factors that propel the market growth. Moreover, rise in research activities to exploit the advantages offered by urinary incontinence devices, surge in healthcare expenditures in developing countries, and new advancements in the technologies offer lucrative opportunities for the market growth.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The involuntary flow of urine due to a loss of bladder control is known as urinary incontinence.

A. The total market value of Global Urinary Incontinence Market is $10,124.33 million in 2020.

A. The forcast period for Global Urinary Incontinence Market is 2021 to 2030.

A. The market value of Global Urinary Incontinence Market in 2030 is $19,341.15 million.

A. Becton, Dickinson and Company (C.R. Bard Inc.), Boston Scientific Corporation, Caldera Medical, Coloplast A/S, ConvaTec Group plc held a high market postion owing to the strong geographical foothold in different regions.

A. Disposables segment dominates the global market, owing to the repetitive use or consumption along with repetitive purchase of urinary incontinence disposables.

A. The major factor for the growth of Global Urinary Incontinence Market are various developments in the urinary incontinence devices, increasing demand for minimally invasive procedures, and shift to novel urinary incontinent products.

A. Owing to rise in the geriatic population in the market. Furthermore, increasing efficiency in the prevention of hospital-acquired infections.

A. The base year is 2020 in Global Urinary Incontinence Market.

A. Urinary incontinence devices aid in collecting and holding urine; such devices help in managing urinary incontinence effectively.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Urinary Incontinence Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers